Product image of Optilamid (Brinzolamide) supplied by GNH India

Optilamid

Active Ingredient:
Brinzolamide
Origin:
EU

Optilamid (Brinzolamide)

Brinzolamide, the active ingredient in Optilamid, is a carbonic anhydrase inhibitor presented as a 1% ophthalmic solution for topical ocular use. It lowers intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension, helping to preserve visual function.

GNH India supplies Optilamid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant documentation for global distribution. Our supply chain supports timely delivery across Europe, Asia and the Americas, ensuring product integrity throughout transport.

Manufacturer / TM Owner

Zaklady Farmaceutyczne Polpharma S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Brinzolamide is a carbonic anhydrase inhibitor used to lower intra‑ocular pressure in glaucoma‑related conditions.

  • Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression
  • Ocular hypertension: lowers pressure to prevent conversion to glaucoma
  • Pseudoexfoliative glaucoma: adjunct therapy to control pressure spikes
  • Secondary glaucoma: helps maintain target intra‑ocular pressure when other agents are insufficient
  • Post‑laser trabeculoplasty: supports sustained pressure reduction after laser treatment

How It Works

  • Brinzolamide inhibits carbonic anhydrase enzymes in the ciliary body epithelium, decreasing the formation of bicarbonate ions. This reduces aqueous humor production, leading to a decline in intra‑ocular pressure. The localized inhibition limits systemic exposure while providing effective pressure control in the anterior chamber of the eye.

Side Effects

Common side effects are generally mild and transient, reflecting local ocular exposure.

Common Side Effects

  • Blurred vision: temporary visual disturbance after instillation
  • Transient eye irritation: mild burning or stinging sensation
  • Altered taste: bitter taste sensation due to nasolacrimal drainage
  • Mild conjunctival hyperemia: slight redness of the eye

Serious or Rare Side Effects

  • Severe allergic reaction (anaphylaxis): requires immediate medical attention
  • Corneal edema: swelling of the cornea affecting vision
  • Significant decrease in visual acuity: notable loss of sharpness
  • Uveitis: inflammation of the uveal tract that may need treatment

Precautions & Warnings

Before using Optilamid, consider the following safety measures.

  • Pregnancy: safety not established; use only if potential benefit justifies the risk
  • Breastfeeding: unknown excretion in milk; weigh maternal benefit against infant risk
  • Renal impairment: monitor intra‑ocular pressure response and adjust therapy as needed
  • Sulfonamide allergy: avoid due to structural similarity that may trigger cross‑reaction
  • Concomitant carbonic anhydrase inhibitors: may increase systemic exposure and adverse effects
  • Store at room temperature: keep in original container, protect from light and moisture

Avoid Interactions

Brinzolamide may interact with other medications; awareness of potential interactions helps maintain safety.

Major Interactions (Avoid)

  • Systemic carbonic anhydrase inhibitors (e.g., acetazolamide): additive intra‑ocular pressure reduction may cause hypotony
  • Sulfonamide antibiotics (e.g., sulfamethoxazole): risk of cross‑reactivity in sulfonamide‑sensitive patients

Moderate Interactions (Monitor Closely)

  • Topical beta‑blockers: combined effect may increase risk of bradycardia or hypotension
  • Topical prostaglandin analogues: monitor for heightened ocular irritation
  • Systemic diuretics: may influence electrolyte balance and affect ocular fluid dynamics

Frequently Asked Questions

Optilamid contains brinzolamide, a carbonic anhydrase inhibitor indicated to lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension. By reducing pressure, it helps to prevent optic nerve damage and preserve visual function.

Brinzolamide blocks carbonic anhydrase enzymes in the eye’s ciliary body, decreasing bicarbonate formation and aqueous humor production. This reduction in fluid lowers intra‑ocular pressure, addressing the primary pathogenic factor in many forms of glaucoma.

The prescribed dosing regimen for Optilamid is determined by the treating ophthalmologist based on individual patient needs, severity of disease, and response to therapy. Patients should follow the specific instructions provided by their healthcare professional.

Safety of brinzolamide in pregnancy has not been established, and it should be used only if the potential benefit justifies any risk to the fetus. During breastfeeding, the drug’s excretion in milk is unknown, so a risk‑benefit assessment is required before use.

To request Optilamid, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Optilamid (brinzolamide) belongs to the carbonic anhydrase inhibitor class, offering a mechanism distinct from beta‑blockers or prostaglandin analogues. It can be used alone or in combination with other classes to achieve additive pressure‑lowering effects, providing flexibility in individualized treatment plans.

Optilamid should be stored at room temperature, below 25 °C, in its original packaging. Protect the bottle from direct sunlight, moisture, and extreme temperature fluctuations to maintain product stability and potency.

Optilamid is applied as eye drops. The patient instills the prescribed number of drops into the affected eye(s) as directed by the ophthalmologist, typically at the same times each day, ensuring the bottle tip does not touch the ocular surface.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, corneal edema, significant loss of visual acuity, and uveitis. Any sudden vision changes or signs of an allergic reaction require immediate medical evaluation.

Optilamid is contraindicated in patients with known hypersensitivity to brinzolamide, sulfonamides, or any component of the formulation. Caution is also advised for individuals with severe renal impairment or those taking systemic carbonic anhydrase inhibitors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Brinzolamide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT